Longeveron share price logo

Longeveron

NASDAQ: LGVN

$2.49

-0.48

(-16.16%)

as on

Longeveron Stock Performance

as on November 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.40
    $2.90
    downward going graph

    3.61%

    Downside

    16.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.31
    $12.30
    downward going graph

    47.39%

    Downside

    393.98%

    Upside

    downward going graph

Longeveron share price movements today

Previous Close
$2.97
Open
$2.90
Volume
292.8K
Market Cap
$9.5M
Day's Low - High
$2.40 - $2.90
52 Week Low - High
$1.31 - $12.30

Longeveron Historical Returns

1 Month Return
+ 43.93 %
3 Month Return
-66.35 %
1 Year Return
-63.47 %
3 Year Return
-98.58 %
5 Year Return
-99.27 %

Longeveron Stock Fundamentals & Key Indicators

Check Longeveron market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

-8.11

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.3

Industry PE ratio

-2.26

PEG Ratio

-0.01

EBITDA

-22.9M

Revenue (TTM)

1.2M

Profit Margin

69.76%

Return On Equity TTM

-223.19%

Longeveron vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Longeveron with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Longeveron image
Longeveron
Buy$9.5M-99.27%-0.3069.76%0.00%
Moderna image
Moderna
Neutral$100.6B0.07%-35.1828.00%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$47.5BNA68.7388.39%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$137.6B187.58%34.7885.57%0.00%
Regeneron image
Regeneron
Buy$99.2B51.37%20.2985.77%0.39%

Stock Returns calculator for Longeveron Stock including INR - Dollar returns

The Longeveron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Longeveron investment value today

Current value as on today

₹38,812

Returns

-₹61,188

(-61.19%)

Returns from Longeveron Stock

-₹63,474 (-63.47%)

Dollar Impact

₹2,286 (+2.29%)

Analyst Recommendation on Longeveron Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Longeveron. Average target price of $61.25

Longeveron Share Price Target

Get share price movements and forecasts by analysts on Longeveron.

What analysts predicted

95.93%UPSIDE

Target Price

$61.25

Current Price

$2.49

Analyzed by

8 Analysts

Target

$61.25

Longeveron target price $61.25, a slight upside of 95.93% compared to current price of $2.49. According to 8 analysts rating.

Indian Investors' Interest in Longeveron Stock

Search interest for Longeveron Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-88% versus previous 30 day period

Longeveron Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-3
-4
-4
-5
-5
-7
-5
-4
-6
-7
EBITDA
-3
-4
-3
-4
-4
-6
-5
-4
-6
-7
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-3
-4
-4
-5
-5
-7
-5
-4
-6
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-4
-4
-5
-5
-7
-5
-4
-6
-6
Net Profit Margin
73.50%
88.23%
87.89%
72.18%
46.20%
91.24%
70.41%
66.33%
63.41%
61.74%

Longeveron Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
5
5
1
1
0
2
1
Gross Profit
0
1
1
0
0
0
1
0
Operating Income
-6
-3
-3
-17
-18
-21
-16
-23
EBITDA
-5
-2
-2
-16
-17
-20
-15
-21
Interest Expense
-
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
1
Income Before Tax
-6
-3
-3
-17
-18
-21
-15
-22
Income Tax Expense
0
-
-
-
-
-
-
-
Net Income
-6
-3
-3
-17
-18
-21
-15
-22
Net Profit Margin
31.88%
32.44%
32.44%
45.18%
40.67%
31.17%
78.76%
66.97%

Longeveron Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-3
-4
-4
-5
-5
-7
-5
-4
-6
-6
Operating Cash Flow
-4
-2
-3
-4
-3
-5
-5
-4
-5
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
15
13
0
0
0
4
0
15
0
0
Change in Cash
10
10
-3
-4
-3
-1
-4
11
-5
-2

Longeveron Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-2
-3
-17
-18
-21
-15
-22
Operating Cash Flow
-5
-2
-2
-9
-13
-19
-13
-18
Investing Cash Flow
0
0
0
-10
0
8
0
0
Financing Cash Flow
1
0
1
45
0
5
28
4
Change in Cash
-4
-2
-1
24
-15
-5
14
-14

Global Institutional Holdings in Longeveron

Check out the Institutions with significant holdings in Longeveron.

Funds
Holdings
Joshua Hare
52.83%
Paul T Lehr
28.31%
Stephen Willard
25.36%
Nataliya Agafonova
23.56%
Devin Blass
23.39%
See all

Longeveron News & Key Events

  • img

    Today's Timeline - 26 October

    Mon, 07:05 PM

    -

    Longeveron reports ELPIS II trial missed primary endpoint but shows fewer adverse events with laromestrocel treatment.

    Tue, 02:49 AM

    -

    Longeveron highlights positive safety findings from ELPIS II trial, showing laromestrocel reduced major cardiac events significantly.

Insights on Longeveron

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LGVN stock has moved up by 37.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 201.4% return, outperforming this stock by 300.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 865.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -4.73M → -6.07M (in $), with an average decrease of 28.2% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 398.0K → 287.0K (in $), with an average decrease of 27.9% per quarter

About Longeveron

Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECEL-B's potential across a diverse range of indications. These include age-related frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Established in 2014, Longeveron Inc. operates from its headquarters in Miami, Florida.
OrganisationLongeveron
HeadquartersLife Science & Technology Park, Miami, FL, 33136, US
IndustryBiotechnology
CEOStephen H. Willard

Key Management of Longeveron

Name

Title

Mr. Brian G Rash Ph.D.

Vice President of Research & Discovery

Dr. Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Executive Chairman

Mr. Paul T. Lehr J.D.

General Counsel & Secretary

Mr. Stephen H. Willard Esq.

CEO & Director

Mr. Nirav Suresh Jhaveri C.F.A., M.B.A.

CFO and Principal Financial & Accounting Officer

Mr. Devin Blass

CTO and Senior VP of Chemistry, Manufacturing & Controls

Ms. Lisa McClain-Moss

Vice President of Manufacturing

Ms. Marie Washburn

VP & Corporate Controller

FAQs

What is Longeveron share price today?

Longeveron share price today is $2.49 as on at the close of the market. Longeveron share today touched a day high of $2.90 and a low of $2.40.

What is the 52 week high and 52 week low for Longeveron share?

Longeveron share touched a 52 week high of $12.30 on and a 52 week low of $1.31 on . Longeveron stock price today i.e. is closed at $2.49,which is 79.76% down from its 52 week high and 90.08% up from its 52 week low.

What is Longeveron's market capitalisation today?

Longeveron market capitalisation is $0.00T as on .

How to invest in Longeveron Stock (LGVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Longeveron on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Longeveron Stock (LGVN) from India?

Indian investors can start investing in Longeveron (LGVN) shares with as little as ₹94.23999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Longeveron stock (as per the Rupee-Dollar exchange rate as on ). Based on Longeveron share’s latest price of $2.49 as on November 14, 2026 at 8:45 am IST, you will get 4.0161 shares of Longeveron. Learn more about fractional shares .

What are the returns that Longeveron has given to Indian investors in the last 5 years?

Longeveron stock has given -99.27% share price returns and 25.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?